ADVFN ADVFN

Hot Features

Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Radiopharm Theranostics Ltd (PK)

Radiopharm Theranostics Ltd (PK) (RDPTF)

0,02
0,00
( 0,00% )
Mis à jour : 13:09:59

Radiopharm Theranostics Ltd (PK) (RDPTF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,02
( - )
Prix Achat
0,01
Prix Vente
1,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,019825 Plage de 52 semaines 0,02
Cap du marché
Clôture Veille
0,02
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 2 722 329
Actions en circulation
3 544 216 160
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-1,05
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess (LTM)
16,28M
Bénéfice net (LTM)
-46,58M

À propos de Radiopharm Theranostics Ltd (PK)

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Carlton, Australia
Fondé
2026
Radiopharm Theranostics Ltd (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker RDPTF. Le dernier cours de clôture d'Radiopharm Theranostics (PK) était de US$0,02. Au cours de la dernière année, les actions de Radiopharm Theranostics (PK) ont été négociées dans une fourchette de prix de US$ 0,019825 à US$ 0,02.

Radiopharm Theranostics (PK) compte actuellement 3 544 216 160 actions en circulation. La capitalisation boursière d'Radiopharm Theranostics (PK) est de US$70,88 million. Radiopharm Theranostics (PK) a un ratio cours/bénéfice (ratio PE) de -1.05.

RDPTF Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
12000.020.020.02933330.02CS
26000.020.020.019825116443780.01982559CS
52000.020.020.01982547646090.01982563CS
156-0.065-76.47058823530.0850.30.000830859740.0198644CS
260-0.07-77.77777777780.090.30.000829980890.01987109CS

RDPTF - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Ltd (PK) share price?
The current share price of Radiopharm Theranostics Ltd (PK) is US$ 0,02
How many Radiopharm Theranostics Ltd (PK) shares are in issue?
Radiopharm Theranostics Ltd (PK) has 3 544 216 160 shares in issue
What is the market cap of Radiopharm Theranostics Ltd (PK)?
The market capitalisation of Radiopharm Theranostics Ltd (PK) is USD 70,88M
What is the 1 year trading range for Radiopharm Theranostics Ltd (PK) share price?
Radiopharm Theranostics Ltd (PK) has traded in the range of US$ 0,019825 to US$ 0,02 during the past year
What is the PE ratio of Radiopharm Theranostics Ltd (PK)?
The price to earnings ratio of Radiopharm Theranostics Ltd (PK) is -1,05
What is the cash to sales ratio of Radiopharm Theranostics Ltd (PK)?
The cash to sales ratio of Radiopharm Theranostics Ltd (PK) is 4,35
What is the registered address of Radiopharm Theranostics Ltd (PK)?
The registered address for Radiopharm Theranostics Ltd (PK) is 62 Lygon Street, Carlton, Victoria, 3053
What is the Radiopharm Theranostics Ltd (PK) website address?
The website address for Radiopharm Theranostics Ltd (PK) is www.radiopharmtheranostics.com
Which industry sector does Radiopharm Theranostics Ltd (PK) operate in?
Radiopharm Theranostics Ltd (PK) operates in the Biotechnology & Life Sciences sector

RDPTF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock